Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor.
Starkebaum G, Loughran TP Jr, Waters CA, Ruscetti FW. Starkebaum G, et al. Among authors: waters ca. Int J Cancer. 1991 Sep 9;49(2):246-53. doi: 10.1002/ijc.2910490218. Int J Cancer. 1991. PMID: 1879969
Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells.
Re GG, Waters C, Poisson L, Willingham MC, Sugamura K, Frankel AE. Re GG, et al. Among authors: waters c. Cancer Res. 1996 Jun 1;56(11):2590-5. Cancer Res. 1996. PMID: 8653702
Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein.
Murphy JR, Williams DP, Bacha P, Bishai W, Waters C, Strom TB. Murphy JR, et al. Among authors: waters c. J Recept Res. 1988;8(1-4):467-80. doi: 10.3109/10799898809049005. J Recept Res. 1988. PMID: 3133472
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
Bacha P, Williams DP, Waters C, Williams JM, Murphy JR, Strom TB. Bacha P, et al. Among authors: waters c. J Exp Med. 1988 Feb 1;167(2):612-22. doi: 10.1084/jem.167.2.612. J Exp Med. 1988. PMID: 3126255 Free PMC article.
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
Walz G, Zanker B, Brand K, Waters C, Genbauffe F, Zeldis JB, Murphy JR, Strom TB. Walz G, et al. Among authors: waters c. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9485-8. doi: 10.1073/pnas.86.23.9485. Proc Natl Acad Sci U S A. 1989. PMID: 2594781 Free PMC article.
Inhibition of HIV-1 RNA production by the diphtheria toxin-related IL-2 fusion proteins DAB486IL-2 and DAB389IL-2.
Zhang L, Waters C, Nichols J, Crumpacker C. Zhang L, et al. Among authors: waters c. J Acquir Immune Defic Syndr (1988). 1992 Dec;5(12):1181-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1453329
Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models.
Bacha P, Forte S, Kassam N, Thomas J, Akiyoshi D, Waters C, Nichols J, Rosenblum M. Bacha P, et al. Among authors: waters c. Cancer Chemother Pharmacol. 1990;26(6):409-14. doi: 10.1007/BF02994090. Cancer Chemother Pharmacol. 1990. PMID: 2225311
Site-directed and deletion mutational analysis of the receptor binding domain of the interleukin-6 receptor targeted fusion toxin DAB389-IL-6.
Jean LF, Waters CA, Keemy D, Murphy JR. Jean LF, et al. Among authors: waters ca. Protein Eng. 1993 Apr;6(3):305-11. doi: 10.1093/protein/6.3.305. Protein Eng. 1993. PMID: 8506265
Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4.
Jabara HH, Vercelli D, Schneider LC, Williams DP, Genbauffe FS, Poisson LR, Waters CA, Geha RS. Jabara HH, et al. Among authors: waters ca. J Allergy Clin Immunol. 1995 Apr;95(4):893-900. doi: 10.1016/s0091-6749(95)70134-6. J Allergy Clin Immunol. 1995. PMID: 7722171
Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
Waters CA, Schimke PA, Snider CE, Itoh K, Smith KA, Nichols JC, Strom TB, Murphy JR. Waters CA, et al. Eur J Immunol. 1990 Apr;20(4):785-91. doi: 10.1002/eji.1830200412. Eur J Immunol. 1990. PMID: 2140788
38 results
Jump to page